Biogen, Inc. (BIIB)
180.44
-0.86
(-0.47%)
USD |
NASDAQ |
Dec 08, 16:00
180.60
+0.16
(+0.09%)
After-Hours: 20:00
Biogen Total Liabilities (Quarterly): 11.00B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 80.52B |
| Eli Lilly & Co. | 91.08B |
| Merck & Co., Inc. | 77.64B |
| Pfizer Inc. | 115.64B |
| Stoke Therapeutics, Inc. | 52.16M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 29.21B |
| Shareholders Equity (Quarterly) | 18.21B |
| Debt to Equity Ratio | 0.3619 |
| Current Ratio | 2.716 |
| Net Debt Paydown Yield | 0.07% |